John Overdeck’s Guardant Health GH Stock Holding History

John Overdeck’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Buy	+14,500	New	+$1.58M	﹤0.01%	2928
2026 Q1	–	Sell	-2,000	Closed	-$204K	–	4714
2025 Q4	$204K	Buy	+2,000	New	+$179K	﹤0.01%	3756
2022 Q1	–	Sell	-8,000	Closed	-$800K	–	3293
2021 Q4	$800K	Buy	8,000 +5,800	+264%	+$600K	﹤0.01%	2767
2021 Q3	$275K	Sell	2,200 -1,700	-44%	-$202K	﹤0.01%	3737
2021 Q2	$484K	Buy	+3,900	New	+$525K	﹤0.01%	3133
2020 Q2	–	Sell	-22,200	Closed	-$1.54M	–	3155
2020 Q1	$1.54M	Buy	22,200 +17,900	+416%	+$1.37M	0.01%	1117
2019 Q4	$336K	Sell	4,300 -3,900	-48%	-$281K	﹤0.01%	3100
2019 Q3	$523K	Buy	8,200 +5,800	+242%	+$511K	﹤0.01%	2522
2019 Q2	$207K	Buy	+2,400	New	+$183K	﹤0.01%	3069

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

John Overdeck's GH Position: Q2 2026 in Review

John Overdeck reduced its Guardant Health (GH) stake by 12% in Q2 2026, selling an estimated $55.5M and leaving 3,719,301 shares worth $558M. The position accounts for 0.4% of the portfolio, ranked #39.

John Overdeck first reported a position in GH in Q3 2019 and has held it in 22 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

John Overdeck held 3,719,301 shares of Guardant Health worth $558M as of Q2 2026.
John Overdeck sold 510,230 Guardant Health shares in Q2 2026, an estimated $55.5M.
Guardant Health made up 0.4% of John Overdeck's portfolio in Q2 2026, its #39 holding.
John Overdeck first reported a position in Guardant Health in Q3 2019 and has held it in 22 quarters since.
595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.